chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Large amount of swelling from the collar bone around her neck; Knee swell; Knee swell with fluid; Hot to touch; Can't walk; Leg swelled up; shooting pains/nerve endings on fire; Fever; Headache; Nausea; Receivedfirst d ose of the Moderna Covid19 vaccine 23March2021, second dose of the Moderna Covid19 vaccine  on 17July2021; flu-like symptoms; Joints that are agitated; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receivedfirst d ose of the Moderna Covid19 vaccine 23March2021, second dose of the Moderna Covid19 vaccine  on 17July2021), INFLUENZA LIKE ILLNESS (flu-like symptoms), MUSCULOSKELETAL DISCOMFORT (Joints that are agitated), BONE SWELLING (Large amount of swelling from the collar bone around her neck) and JOINT SWELLING (Knee swell) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 078C21A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receivedfirst d ose of the Moderna Covid19 vaccine 23March2021, second dose of the Moderna Covid19 vaccine  on 17July2021). 17-Jul-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), MUSCULOSKELETAL DISCOMFORT (Joints that are agitated), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea). On 19-Jul-2021, the patient experienced BONE SWELLING (Large amount of swelling from the collar bone around her neck), JOINT SWELLING (Knee swell), JOINT EFFUSION (Knee swell with fluid), FEELING HOT (Hot to touch), GAIT INABILITY (Can't walk), PERIPHERAL SWELLING (Leg swelled up) and PAIN (shooting pains/nerve endings on fire). On 17-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Receivedfirst d ose of the Moderna Covid19 vaccine 23March2021, second dose of the Moderna Covid19 vaccine  on 17July2021) had resolved. On 18-Jul-2021, INFLUENZA LIKE ILLNESS (flu-like symptoms), MUSCULOSKELETAL DISCOMFORT (Joints that are agitated), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea) had resolved. At the time of the report, BONE SWELLING (Large amount of swelling from the collar bone around her neck), JOINT SWELLING (Knee swell), JOINT EFFUSION (Knee swell with fluid), FEELING HOT (Hot to touch), GAIT INABILITY (Can't walk), PERIPHERAL SWELLING (Leg swelled up) and PAIN (shooting pains/nerve endings on fire) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jul-2021, Urine output: increased (High) urinating profusely.         No relevant concomitant medication were provided. No treatment information was provided. Patient reported that a nurse practitioner is treating her symptoms.
This case was reported by a pharmacist and described the occurrence of red rash injection site in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). In October 2008, the subject received a dose of FLUARIX (.5 ml, unknown). In October 2008, at an unspecified time after vaccination with FLUARIX, the subject experienced red rash injection site and pharmaceutical product complaint. The pharmacist received a call from a nurse at a nursing home facility that reported that 80 out of 100 subjects developed a "grapefruit size bright red" rash at the injection site. At the time of reporting the outcome of the events were unspecified. For the other 79 linked subjects please see cases: A0756483A - A0756532A, A0756534A - A0756562A. The CRC provided lot number AFLUA3208A to QA regarding this product complaint, while the report received in CMG Safety stated AFLUA3508A. With a possibility of a coding mistake to batch AFLUA320AA and on the basis that there are 80 cases out of 100, it was decided to ask for a Quality investigation (including cold chain) of all three batches (correct numbers: AFLUA350BA, AFLUA320BA and AFLUA320AA). On 16 January 2009, QA results were received for batches reviewed of (AFLUA320AA and AFLUA320BA): AFLUACA320, AFLUA320A, and AFLUA320B. The report indicated that no deviation that could be linked to the complaint and no cold chain deviation was recorded on the batches AFLUA320AA and AFLUA320BA. On 26 March 2009, QA results were received for batches reviewed (AFLUA350BA): AFLUCA350 and AFLUA350B. The report indicated that no deviation that could be linked to the complaint and no cold chain deviation was recorded on the batch AFLUA350BA.
Pt administered Flublok at age 8 by accident when recommendation is only for 18+ years. Contacted parent to make aware of error and to monitor child for side effects. No additional vaccines will be needed to make up for error
On 10/16/2022, I had a runny nose and postnasal drip. I tested myself for COVID-19 and it was negative. On 10/17/2022, I had the same symptoms, and some added mild fatigue. I tested negative for COVID-19 again that day. That evening, I developed a low-grade fever of 100 degrees that I treated with a single dose of Ibuprofen and the fever never returned. My wife had tested positive, so I was convinced that my symptoms were the same, so on 10/18/2022, I went to be tested at a local pharmacy and it was positive. I was already beginning to feel better and by 10/19/2022, I was basically asymptomatic. I had a telehealth visit with my doctor who informed me that I could take Paxlovid, but he felt I did not really need it. I declined the anti-viral since my symptoms were minimal. I tested myself again on either 10/22 or 10/23 and I was negative.
Injection given IM (R) delt., PNEUMOVAX vaccine.  05cc) Merck 0867 exp 12/4/09. Patient c/o chills arm swell, and redness with discomfort instructed to take IBUPROFEN. Swelling/redness over entire proximal arm.
Patient brought to ER with a fever above 101 and with weakness. Treatment includes Paxlovid, assessment and supportive care.
Redness at injection site. Soreness, Hot to the touch. NO Itching. Referred patient to their medical provider. instructed to use cold compress and Benadryl.
Immunization was given by nurse in IM site instead of in the sub Q. No problems reported.
Pt. received Dtap, Hep A vaccines. After walking to parking lot, mom returned with child. She had been crying throughout procedure, now had red "whelps" on various areas of face, neck & arms. She was not having any respiratory problems.
No other AE; we gave a 18month old her 2nd Hep A shot today. Her first one was at her 12 month appointment on 3/16/23. So we are early about 4 Days; This spontaneous report was received from other health professional and refers to an 18-month-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 16-MAR-2023, the patient was vaccinated with her first dose of hepatitis a vaccine, inactivated (manufacturer unknown) administered for prophylaxis (dose, anatomical location, lot #, expiry date, and route of administration were not provided). On 12-SEP-2023, the patient was vaccinated with her second dose of hepatitis a vaccine, inactivated (manufacturer unknown) administered for prophylaxis (dose, anatomical location, lot #, expiry date, and route of administration were not provided), so they were early about 4 Days (Inappropriate schedule of product administration). No other adverse events (AE) experienced (No adverse event).
I felt soreness, fever, aches, tight chest, joint swelling. I could not breath, I had shortness of breath. I had to go to the hospital on 07/01/2022. It triples my Arthritis. I had to see orthopedics. I had a fracture in your spine. They sent me home with inhaler and pain medications. I had to go back in and out the hospital on 07/03/2022 and 07/06/2022. I saw my PCP on 07/07/2022. I also had to see a cardiologist. I had to be out of work for two months and when I went back I had a really hard time.
Information has been received from an 84 year old female consumer with no pertinent medical history and no drug reactions/allergies, who on 09-NOV-2007 was vaccinated SC with a .65 mL dose of ZOSTAVAX (Merck). Concomitant medication included "blood pressure medication" (manufacturer unknown). On 11-NOV-207 the patient developed "red spots" on her arm at injection site. At first it was a "stabbing pain" and then a "burning pain" and later progressed to " a lot of pain". The patient stated that the adverse event did not improve. There were no lab diagnostic studies performed. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested. This is in follow-up to report(s) previously submitted on 12/23/2007; 3/26/2008. Information has been received from an 84-year-old female consumer with no pertinent medical history and no drug reactions/allergies, who on 09-NOV-2007 was vaccinated subcutaneously with 0.65 mL dose of ZOSTAVAX (Merck). Concomitant medication included "blood pressure medication" (manufacturer unknown). On 11-NOV-2007 the patient developed "red spots" on her arm at the injection site. At first it was "stabbing pain" and then it was "burning pain" and later progressed to "a lot of pain". The patient stated that the adverse event did not improve. There were no lab diagnostics studies performed. Unspecified medical attention was sought. There was no product quality complaint. Follow-up information has been received from the physician concerning a patient with allergies to penicillin and sulfa who was vaccinated in the AM on 09-NOV-2007 in the left arm with a first dose of ZOSTAVAX (Merck) (lot# 65862/1415U). Concomitant medications included DIOVAR, Verapamil, "hyorclatine" and "spirivc". On 12-NOV-2007 the patient presented with shingles along the right chest wall. It was unspecified if the patient sought medical attention via the emergency room or a doctor visit. On an unspecified date the patient recovered.
WITHIN AN HOUR AFTER LEAVING DOCTORS OFFICE MY ARM STARTED SWELLING, WAS RED, ITCHY, PAINFUL, AND WARM TO THE TOUCH. SWELLING CONTINUE TO SPREAD OUT, AND UP AND DOWN THE ARM TO MY SHOULDER AND TO MY ELBOW. I RETURNED TO DOCTORS OFFICE AT 01:00 PM SAME DAY AND THEY PRESCRIBED ME PREDNISONE 10MG AND BACTRIM WHICH I AM STILL TAKING AS OF TODAY. SWELLING HAS GONE DOWN AS OF 5/24/15.
At 6pm, I started feeling  nauseous, crampy and then like a ton of bricks I had to lie down.  I was shaking uncontrollably with a very high  fever and chills for two hours.  I couldn't eat.  I fell asleep for an hour and woke up feeling terrible- headache, fever, muscle aches, and sweating.  The next four days I had a headache and shortness of breath.   I am on day  8 now  and still  feel extremely tired.
8 days after the vaccine, I developed hives/ a rash throughout my torso and upper thighs.  The primary breakout is my chest.  There is also a large welt at the injection site.  The breakout is itchy and warm.  It has not gone away yet.
I have felt fatiqued, run down and genrally not well since receiving the Covid booster and flu shot 9 days ago.  Some abnormal chest congestion.  Feel "fluish".    No fever.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On 14-MAR-2016, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # L050909, expiry date: 14-JUN-2017, (dosing details, route and strength were not reported). It was reported that the vaccine was exposed to the temperature of 6F for a time frame of 15 hours. Previous temperature excursions were reported as 7F for 24 hours on 16-MAR-2016 and 10F for 24 hours on 11-MAR-2016. No adverse effects were reported. There were no product quality complaints (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
Sweating, Dizziness BP 106/55, HR 78, RR 13 -- > 104/65,62,24 -- > 121/62, 61.  Patient stable and released from the vaccination site
The patient received a flu shot in her right arm and the next day she noticed it started to swell and turn red. Three days later she realized that it was getting worse and came to the pharmacy. By then it was 3 inches in diameter.
Nausea, Headache, Joint swelling (couldnt make a fist), Pins and Needles on palms of hands, Pins and Needles bottom of feet,Burning feeling the bottom of feet, body aches, fatigue. No treatment.  Event ended 30 hours after vaccine.
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Lot number: Unknown) as dose number unkown (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: TYMLOS taken for osteoporosis.The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster"; CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "Tymlos, it''s for Osteoporosis and I have to inject myself everyday with this".No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was given a fourth dose of a full dose Moderna Covid-19 vaccine.  Current orders are only for a 3rd full dose of Moderna for Immunocompromised.  No adverse reactions, error in additional vaccination.
Received shot on 9/23/08 pt called 9/26/08 reported swelling, itching & blister at site of injection.  Pt did stop by and a blister with swelling & redness was confirmed.  Pt has no fever or systemic symptoms.  Slightly worried about blister due to the live vaccine.
Muscle soreness at injection site; Headache; General fatigue; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 04Mar2021 at 13:15 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 from an unknown date. The patient had no allergies to food, medications, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Mar2021 at 07:00, the patient experienced muscle soreness at injection site, headache and general fatigue, all symptoms resolved after 36 to 48 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle soreness at injection site, headache and general fatigue were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
pt recv vax 22OCT96 & 23OCT96 pt devel vomiting & diarrhea w/o fever 48hr p/vax;pharmacist related were other pt that exp vomiting & diarrhea who did not recv vax;this is 1 of 25 reports;
Shingles; This case was reported by a consumer and described the occurrence of shingles in a 58-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25th September 2019, the patient received the 1st dose of Shingrix. On 21st January 2020, 118 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The NDC number was provided as 58160-0823-11. The patient received Shingrix and had Shingles on 21st January 2020, 29th January 2020 and 1st March 2020. The patient was put on medicine for 6 months and had 10 *5 they talked into shots. The patient still got 6*5 for shot plus. The reporter thinks he/she deserve money back after both doses. For tolerances of 2nd dose, refer case US2020AMR112954, reported by same reporter for the same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR112954:same reporter
First vaccination 3/9/21 Soreness in upper left arm (injection site). Dates: 10th-12th Redness and swelling at injection site. Date: 12th Fatigue and unusual sleepiness, improved with additional sleep than normal (naps, going to bed early) Dates: 13th- 15th  General muscle soreness that may or may not be related to vaccine (since chronic muscle pain is present in patient) Dates: 13th-17th   Second Vaccination 3/30/21 Little to no side effects from second vaccination.   Some general muscle soreness.
Report on admission: Patient is a 65 y.o. year-old male, who presented with SOB to the ED yesterday (1/16). Patient has had cough, rhinorrhea, and congestion for 3wks. On 1/16 he presented to his PCP and was found to have low O2, which prompted him to come to the ED. His initial O2 saturation upon arrival to the ED was 80% with RR of 17. Patient denies SOB, chest pain, loss of taste/smell, numbness or tingling. Patient states he has been able to hear himself wheezing occassionally while breathing. With his cough he has been occassionally spitting up small amounts of "gray" colored sputum. Patient was a previous smoker but stopped 10-12 years ago. Since then he has been cycling and improving his diet. He has a history of hypertension which is controlled with amlodipine and losartan.     Hospital course as below.  Pulmonology followed patient during stay.  Patient improved with medical treatment.  Patient discharged home in stable condition.     1. COVID pneumonia .Covid-19 Virus Infection Date of onset of symptoms:  3 weeks ago Symptoms present on admission: Hypoxemia/cough Date of covid positive test:  1/16/23 Vaccination status:  vaccinated x3 Imaging:   CTPA and CXR reviewed. Oxygen requirements on admission:   15 L NC Medical therapy: decadron, not a candidate for remdesivir Consultants following:  pulmonology Anticipated special isolation end date: 10 days from diagnosis as long as clinically improving.   2. Acute respiratory failure             - Continue to wean as able             - Incentive spirometer while awake.   3. Community acquired pneumonia             - Continue with antibiotic.             - Cultures pending             - Pulmonology following  -Repeat imaging outpatient in March   4. Hypertensive heart disease             - continue to monitor.             - continue home meds
Initially I experienced severe headache, fatigue, fever, tight chest and short breath and swelling in my hands such that I couldn?t get my ring off.  I am still experiencing varying degrees of headache and fatigue that is at times preventing my working.
left thigh and the redness is about 5 in X 4 in, hot to touch, swollen and painful.
Pt recv vax on 4/13/99; on 4/14/99 pt exp body aches/ pains
Pt started feeling aches and body pain, headache and chills a few hours after receiving the HPV and MENACTRA vaccines.
TD was given SubQ. Approx. 36-48 hours after injection, patient developed an area apprx. 4-5 in long x 3-4 in wide of red, warm to touch, swollen , and very tender in back of arm where injected. Missing vaccine information was not available.
Presented w/ sore throat and Covid+ test approx 1 week prior. Increasingly fatigued w/ weakness. Low grade fever. Tx w/ IX steroids, Remdesivir for Covid pneumonia, O2 support for hypoxia.
One week after being administered my first dose of the Moderna vaccine, I noticed a hard lump on my arm at the injection site. The lump was red, a little warm to the touch, and felt sore. This continued for 1-2 days. First the swelling went down and then at the end of the second day it was just a little sore still, but otherwise fine.
2 days post anthrax #2, left arm, reports with malaise, subjective fever, left arm pain and tender shoulder - to immediately proximal to elbow. Shoulder motion painful treated and supportive measures, NSAID analgesia.
PT'S RHEUMATOID ARTHRITIS FLARED UP AFTER VACCINE. EVERY JOINT FELT PAIN AND SWELLING
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 15-MAY-2014 the patient was vaccinated with a dose of PROQUAD that was exposed to temperatures outside of the recommended range (dose, route, indication and lot # not reported). No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
Patient received first Moderna COVID19 vaccination on 04/15/2021. Patient's second Moderna appointment had been rescheduled for 5/14/2021. Patient came on 5/13/2021, a day the pharmacy was only giving Pfizer COVID19 vaccination. A Pfizer vaccination was given instead of Moderna.
105 degree fever and bodily aches. Lasted about 12 hours. A few months later Type 2 Diabetes diagnosis.
mom called 19SEP94 to stat pt had a sz 31JUL94 13 days p/vax; stated MD relate it to roseola, but mom not convinced;
I experienced about three weeks after my vaccine, I developed headaches that came and and my headaches have became worse with time passing to the point I am not eating or sleeping. I do not know what is happening with me. I have a doctor's appointment next week to see my doctor and I am really anxious and crying about how I am feeling about my headaches that wont go away.
After vaccination he had a fever of 103 for 4 days that resolved. After 10 more days a low grade fever and rash developed for a day. Since that time, parents noted developmental regression. Previously saying "mama and dada" and interacting with parents. He stopped responding to ques. He was referred to psychologist and dx with autism. He has a twin who is developmentally normal. Met milestones for development at well visits before vaccination.
I waited too long in between the first and second dose; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose in January 2020).   In April 2022, the patient received the 2nd dose of Shingles vaccine. In April 2022, unknown after receiving Shingles vaccine, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 18-APR-2022 Reporter's comment: This case was reported by patient via interactive digital media. The patient received second dose of Shingles vaccine two weeks ago before the day of reporting. The patient asked for whether he/she required third dose because he/she waited too long in between first and second dose of Shingles vaccine.  The patient was not comfortable for giving his/her personal information. Additional Supportive Information: The patient received the second dose later than the recommended interval, which led to lengthening of vaccination schedule.
Patient was given a 4th dose of Covid vaccine when he was not 50 years old or immunocompromised. Patient had no abnormal symptoms or reaction.
Patient received Moderna 6mo-5yrCOVID vaccine instead of Pfizer 5-11 Year Bivalent Vaccine.